Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Haemonetics (HAE) Goodwill (2016 - 2025)

Haemonetics has reported Goodwill over the past 16 years, most recently at $606.8 million for Q4 2025.

  • Quarterly results put Goodwill at $606.8 million for Q4 2025, changed 0.26% from a year ago — trailing twelve months through Dec 2025 was $606.8 million (changed 0.26% YoY), and the annual figure for FY2025 was $604.3 million, up 6.93%.
  • Goodwill for Q4 2025 was $606.8 million at Haemonetics, roughly flat from $606.1 million in the prior quarter.
  • Over the last five years, Goodwill for HAE hit a ceiling of $616.2 million in Q3 2024 and a floor of $465.0 million in Q4 2022.
  • Median Goodwill over the past 5 years was $468.4 million (2021), compared with a mean of $525.5 million.
  • Biggest five-year swings in Goodwill: surged 121.43% in 2021 and later decreased 1.63% in 2025.
  • Haemonetics' Goodwill stood at $468.6 million in 2021, then fell by 0.53% to $466.1 million in 2022, then increased by 19.07% to $555.0 million in 2023, then increased by 9.06% to $605.3 million in 2024, then grew by 0.26% to $606.8 million in 2025.
  • The last three reported values for Goodwill were $606.8 million (Q4 2025), $606.1 million (Q3 2025), and $607.3 million (Q2 2025) per Business Quant data.